OptimizeRx Corp — Director's Dealing 2016

Jul 29, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: OptimizeRx Corp (OPRX)
CIK: 0001448431
Period of Report: 2016-07-28

Reporting Person: Dillon Brian J (SR. VP OF PRODUCT & STRATEGY)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-07-28	Option	$1.15	A	100000	Acquired	2021-07-28	Common Stock (100000)	Direct

Footnotes

F1: The option vests 50% on July 28, 2017 and 50% on July 28, 2018.